Non-invasive biomarkers and scoring systems show strong capability in differentiating chronic liver disease from cirrhosis, ...

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

Global research into the gut microbiome has exploded over the past decade, with most of the spotlight shining on the complex, ...

In the study population of more than 30,000 people without known liver disease, the proportion of persons with a liver ...

Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

The three-member panel formed by Chief Minister N Chandrababu Naidu analysed health data from Arogyasri, a flagship scheme ...

To test their new drug, the researchers conducted experiments on mice that were fed a high-fat diet, which typically leads to ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

Metabolic liver disease might not get as much attention as heart disease or diabetes, but it affects around one in four ...

Approximately 850 people underwent free liver scans this week at the RAI Amsterdam convention center, where the European ...